Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02523313
What this trial is testing

Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 167
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)UnknownNCT00991250
What this trial is testing

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
SentoClone AB 140
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Not applicableStudy completedNCT01719562
What this trial is testing

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Who this might be right for
Cardiac ToxicityMalignant NeoplasmBreast Cancer
Wake Forest University Health Sciences 28
Not applicableStudy completedNCT00972010
What this trial is testing

Study to Evaluate Surgical Excision Margins in Malignant Breast Lumpectomies With the PEAK PlasmaBlade

Who this might be right for
Breast Cancer
Sarah Blair, M.D. 21
Not applicableTemporarily pausedNCT03987555
What this trial is testing

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Who this might be right for
Solid Tumor, AdultMetastatic Nonsmall Cell Lung CancerAnatomic Stage IV Breast Cancer AJCC v8+25 more
Wake Forest University Health Sciences 55
Early research (Phase 1)Study completedNCT01765543
What this trial is testing

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 27
Early research (Phase 1)Ended earlyNCT04653038
What this trial is testing

Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Who this might be right for
Unresectable, Recurrent or Metastatic MelanomaUntreated Mucosal or Acral Lentiginous Melanoma
Zai Lab (Shanghai) Co., Ltd. 92
Not applicableStudy completedNCT05148455
What this trial is testing

Pregnancy-related Changes in Melanocytic Nevi

Who this might be right for
Melanocytic Nevi (MN)
University Hospital, Basel, Switzerland 50
Testing effectiveness (Phase 2)Ended earlyNCT04109482
What this trial is testing

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mustang Bio 3
Testing effectiveness (Phase 2)Ended earlyNCT00145158
What this trial is testing

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Who this might be right for
Malignant Melanoma
Ludwig Institute for Cancer Research 23
Testing effectiveness (Phase 2)Study completedNCT05159778
What this trial is testing

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Who this might be right for
Malignant Neoplasm of Breast
HiberCell, Inc. 26
Testing effectiveness (Phase 2)UnknownNCT02142335
What this trial is testing

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Who this might be right for
Malignant Melanoma of Skin Stage IIIMetastatic Melanoma
California Cancer Assocaties for Research & Excellence 17
Large-scale testing (Phase 3)Study completedNCT01953003
What this trial is testing

Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Who this might be right for
Malignant Neoplasm of Breast
Pierre Fabre Medicament 112
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Early research (Phase 1)Ended earlyNCT02250118
What this trial is testing

Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer

Who this might be right for
Pleural Effusion, MalignantBreast Cancer
Institut Curie 1
Testing effectiveness (Phase 2)Looking for participantsNCT06518057
What this trial is testing

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more
University of Washington 22
Testing effectiveness (Phase 2)Study completedNCT00498836
What this trial is testing

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Clavis Pharma 18
Early research (Phase 1)UnknownNCT02441972
What this trial is testing

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Who this might be right for
TumorsCarcinoma, BronchogenicBreast Carcinoma+3 more
Wuxi No. 4 People's Hospital 200
Next Page